Skip to main content
 

Biosimilars Forum Encouraged By Food And Drug Administration Commissioner’s Support of Biosimilars

Washington, D.C., March 9, 2018 – The Biosimilars Forum is encouraged by Food and Drug Administration (FDA) Commissioner Scott Gottlieb’s support of a vibrant biosimilars market and his efforts to highlight barriers preventing the U.S. healthcare system from fully benefiting from the promise of biosimilars. It is clear that the FDA recognizes the benefits biosimilars can provide to patients, physicians and the entire health care system. Now more than ever, we need policies that inspire investment in biosimilars and greater competition, as this will ultimately bring more drugs to market, lower the cost of safe and effective treatment options, and improve patient access to care.


About the Biosimilars Forum

The Biosimilars Forum is a nonprofit organization whose mission is to advance biosimilars in the United States with the intent of expanding access and availability of biological medicines, and improving health care. The founding members of the Biosimilars Forum represent the majority of companies with the most significant U.S. biosimilars development portfolios.

To learn more about biosimilars, the Forum, and how to get involved, visit BiosimilarsForum.org, @USbiosimilars, or Facebook/USBiosimilars to follow related conversations and join the dialogue.

Contact:
Aimee Steel Lubin
202.828.1895
aimee.lubin@hklaw.com

Date

Friday, March 9, 2018